Stada Group
Dr. Aurica-Maria Kaufeld is a highly experienced professional in the field of quality assurance and compliance within the pharmaceutical and health care industries. Currently serving as Senior Manager for Global Quality Supplier & Auditing Management/QP at STADA Group, Dr. Kaufeld has previously held significant positions at Evonik, including Head of Quality Assurance - Material and Compliance Systems, and at Berlin-Chemie Menarini, focusing on GMP compliance and quality control. Dr. Kaufeld's academic background includes a Ph.D. in Pharmacology and an MBA from the Berlin Professional School, complemented by various roles as a researcher and pharmacist. Dr. Kaufeld's expertise encompasses auditing, quality control, and documentation management, with a solid foundation in regulatory compliance and product lifecycle management.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.